View in EDS

Multiple-Dose Administration of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Does Not Alter the Single-Dose Pharmacokinetics of Rosiglitazone in Healthy Subjects.

Saved in:
Bibliographic Details
Title: Multiple-Dose Administration of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Does Not Alter the Single-Dose Pharmacokinetics of Rosiglitazone in Healthy Subjects.
Authors: Goutam GCM Mistry1, Arthur AJB Bergman1, Wen-Lin WL Luo1, Caroline CC Cilissen2, Wouter WH Haazen3, Michael MJD Davies1, Keith KMG Gottesdiener1, John JAW Wagner1, Gary GAH Herman1
Source: Journal of Clinical Pharmacology. Feb2007, Vol. 47 Issue 2, p159-164. 6p.
Database: Academic Search Ultimate
Description
ISSN:00912700
DOI:10.1177/0091270006297007